Countries China
Merck Invests €70 Million to Expand Reagent Manufacturing in China
Adds production capacity to further provide customers with highly purified reagents for quality control and testing Major investment at company’s ...
July 04, 2023 | News
Innovent and IASO Bio Receive NMPA Approval for FUCASO®, a Fully-human BCMA CAR-T Therapy for Multiple Myeloma
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
July 03, 2023 | News
Chime Biologics, Leads Biolabs, and BeiGene Join Forces to Advance LBL-007 mAb Globally
Leads Biolabs and Chime Biologics initiate strategic cooperation to accelerate IND application and provide clinical trial materials in China. BeiGe...
July 03, 2023 | News
Harbour BioMed's Batoclimab Receives NMPA Acceptance for Generalized Myasthenia Gravis Treatment
"Anti-FcRn treatment is at the center of focus in gMG disease area. Batoclimab is the first anti-FcRn treatment completed clinical development with po...
June 30, 2023 | News
BGI Genomics obtains BSI ISO 37301 Compliance Management System Certification
BGI Genomics prioritizes compliance management and strictly follows laws, regulations, and international practices while conducting business globally. BGI ...
June 30, 2023 | News
Sanyou Partners with Hangzhou Zhongmei Huadong Pharmaceutical to Drive Drug R&D
This license is a continuation of the strategic partnership agreement signed by both parties in Nov. 2020. As a cutting-edge high-tech biotechnology e...
June 29, 2023 | News
Verona Pharma Partners with Nuance Pharma, Submits Ensifentrine NDA to US FDA for COPD Maintenance Treatment
Ensifentrine is a selective dual inhibitor of the enzymes phosphodiesterase 3 and 4 combining bronchodilator and non-steroidal anti-inflammatory activities...
June 29, 2023 | News
OBiO Technology adds scale-X™ and NevoLine™ Upstream Platform to Accelerate Gene Therapy Manufacturing in Shanghai
The strategic agreement combines the capacity and capabilities of OBiO process development (PD) scientists with enabling platforms and support from...
June 28, 2023 | News
Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership
As leaders in their respective fields, this strategic partnership marks an important milestone in both companies' business growth and development. Also, it...
June 28, 2023 | News
CStone Receives China NMPA Approval for GAVRETO® in First-Line Treatment of RET Fusion-Positive Lung Cancer.
The approval for the first-line treatment of RET fusion-positive non-small cell lung cancer marks the third indication of GAVRETO in Mainland Chi...
June 27, 2023 | News
HitGen Launches Upgraded OpenDEL™ Kit in China to Enhance Drug Discovery Research.
OpenDEL™ is a self-service DNA-encoded library (DEL) kit, which enables users to explore DEL selection campaigns without revealing the target identit...
June 27, 2023 | News
Innovent and RemeGen Collaborate on Clinical Trial for Combined Therapy of TYVYT® and Novel ADCs in China
Under the agreement, Innovent will provide clinical drug supplies of TYVYT® (sintilimab injection) during the clinical trial collaboration. RemeGen wil...
June 26, 2023 | News
Brii Biosciences to Sell Equity Interest in Qpex Biopharma and Acquire Global Rights for BRII-693
Company acquires exclusive global rights of the novel lipopeptide BRII-693 for the difficult to treat MDR/XDR gram-negative bacterial infections &nbs...
June 26, 2023 | News
Everest Medicines' Partner Calliditas Presents Nefecon Data at ERA-EDTA Congress
The presentations showed data and analyses from the NefIgArd Phase 3 clinical trial evaluating Nefecon in patients with IgA nephropathy (IgAN). The study m...
June 21, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
